A retrospective observational analysis of the real-world care pathway of people with hereditary transthyretin amyloidosis with polyneuropathy in Italy [0.03%]
意大利遗传性转甲状腺素蛋白淀粉样变性患者的回顾性观察分析
Silvia Calabria,Giulia Ronconi,Letizia Dondi et al.
Silvia Calabria et al.
Background: This retrospective observational study described the epidemiology and the burden on the Italian healthcare service (SSN) of patients with polyneuropathy (PN) associated to the hereditary transthyretin amyloido...
Caroline Daccache,Rana Rizk,Mickaël Hiligsmann et al.
Caroline Daccache et al.
Background: Economic evaluation guidelines (EEGs) serve as a valuable tool to assist appraisers in making consistent and transparent recommendations, standardize EE studies, enhance their quality, and minimize methodologi...
Medication adherence in rheumatoid arthritis: implications for cardiovascular disease risk and strategies to address in U.S. Veterans [0.03%]
风湿性关节炎患者的用药依从性及其对美国退伍军人心血管疾病风险的影响及应对策略
Isaac D Smith,Bryant R England,Neha J Pagidipati et al.
Isaac D Smith et al.
Introduction: Rheumatoid arthritis (RA) is a systemic inflammatory disease associated with an increased risk of cardiovascular disease (CVD) and premature mortality. The risk of CVD is closely associated with RA disease a...
Clinical and economic impact analysis of viscosupplementation with hylan G-F 20 versus hyaluronic acids and no viscosupplementation for the treatment of knee osteoarthritis in Colombia [0.03%]
玻尿酸和无治疗 vs 将透明质酸凝胶用于膝关节炎的临床与经济影响分析（哥伦比亚）
Eliana C Vásquez Melo,Pieralessandro Lasalvia,Lina Maria Gómez Espitia et al.
Eliana C Vásquez Melo et al.
Background: Viscosupplementation is a viable alternative for managing knee osteoarthritis, showing potential to delay the need for total joint replacement in affected patients. ...
Disparities in Respiratory Syncytial Virus Risk Factors, Diagnosis, and Outcomes in Adults by Race, Ethnicity, and Other Social Determinants of Health in the United States [0.03%]
美国成人呼吸道合胞病毒风险因素、诊断和结局的种族、族裔和其他社会健康决定因素差异
Emily K Horn,Elizabeth M La,Meryem Bektas et al.
Emily K Horn et al.
Introduction: Respiratory syncytial virus (RSV) vaccination could improve health equity by protecting individuals who are disproportionally at increased risk of RSV infection and severe RSV-related outcomes. However, limi...
Is the shift in treatment patterns towards new, more expensive drugs still driving the increase in pharmaceutical expenditure? A decomposition analysis of expenditure data in Sweden 1990-2022 [0.03%]
1990年至2022年瑞典药品支出数据的分解分析：新药和高价药对支出增长的影响几何？
Marie-Catherine Schaller,Ulf-G Gerdtham,Johan Jarl
Marie-Catherine Schaller
Background: Pharmaceutical expenditures (PE) are increasing worldwide, raising concerns about sustainability. However, the current price index provides an incomplete picture of this trend due to the rapid introduction of ...
Economic cost of hemodialysis and peritoneal dialysis under public-private partnership in a public tertiary care centre of Puducherry, India [0.03%]
印度浦那地区公立三级医疗中心合作下的血液透析和腹膜透析的成本分析研究
Vanjavakam Sahithya,Parthibane Sivanantham,Jeyanthi Anandraj et al.
Vanjavakam Sahithya et al.
Background: India faces over 220 000 lakh new kidney failure cases annually, requiring approximately 34 million dialysis sessions, creating a significant economic burden on the healthcare system. This study estimates the ...
Cost-effectiveness studies of brexu-cel for relapsed/refractory B-cell acute lymphoblastic leukemia and mantle cell lymphoma: a systematic review [0.03%]
倍林妥莫双抗治疗复发/难治B细胞急性淋巴细胞白血病和套细胞淋巴瘤的成本效果研究系统评价
Asmita Priyadarshini Khatiwada,Ahmed Mostafa Ahmed Kamel,Nathorn Chaiyakunapruk et al.
Asmita Priyadarshini Khatiwada et al.
Introduction: This systematic review aims to explore the existing evidence on the cost-effectiveness of brexu-cel across different international jurisdictions. ...
Regulatory perspectives on post-market evidence generation schemes for high-risk medical devices: a systematic review [0.03%]
关于高风险医疗器械上市后证据生成方案的监管观点：系统性综述
Jesús Aranda,Agnieszka Dobrzynska,Maria Piedad Rosario-Lozano et al.
Jesús Aranda et al.
Introduction: The new European Medical Device Regulation has raised the bar for the clinical evaluation of medical devices to gain marketing authorization by Notified Bodies (NBs) regarding certificates of conformity in E...